Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma
Open Access
- 1 May 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (6), 2616-2628
- https://doi.org/10.1172/jci64503
Abstract
Primary effusion lymphoma (PEL) is a rare form of aggressive B cell lymphoma caused by Kaposi’s sarcoma-associated herpesvirus (KSHV). Current chemotherapy approaches result in dismal outcomes, and there is an urgent need for new PEL therapies. Previously, we established, in a direct xenograft model of PEL-bearing immune-compromised mice, that treatment with the proteasome inhibitor, bortezomib (Btz), increased survival relative to that after treatment with doxorubicin. Herein, we demonstrate that the combination of Btz with the histone deacetylase (HDAC) inhibitor suberoylanilidehydroxamic acid (SAHA, also known as vorinostat) potently reactivates KSHV lytic replication and induces PEL cell death, resulting in significantly prolonged survival of PEL-bearing mice. Importantly, Btz blocked KSHV late lytic gene expression, terminally inhibiting the full lytic cascade and production of infectious virus in vivo. Btz treatment led to caspase activation and induced DNA damage, as evidenced by the accumulation of phosphorylated γH2AX and p53. The addition of SAHA to Btz treatment was synergistic, as SAHA induced early acetylation of p53 and reduced interaction with its negative regulator MDM2, augmenting the effects of Btz. The eradication of KSHV-infected PEL cells without increased viremia in mice provides a strong rationale for using the proteasome/HDAC inhibitor combination therapy in PEL.Keywords
This publication has 55 references indexed in Scilit:
- Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer CellsThe American Journal of Pathology, 2011
- Efficacy of bortezomib in a direct xenograft model of primary effusion lymphomaProceedings of the National Academy of Sciences of the United States of America, 2010
- Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Protein Is Necessary for Lytic Viral Gene Expression, DNA Replication, and Virion Production in Primary Effusion Lymphoma Cell LinesJournal of Virology, 2009
- Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected CellsJournal of Biological Chemistry, 2009
- Acetylation Is Indispensable for p53 ActivationCell, 2008
- Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Downregulates Nuclear Glycogen Synthase Kinase 3 Activity and Consequently Blocks DifferentiationJournal of Virology, 2007
- Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomasJCI Insight, 2007
- In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's SarcomaCancer Cell, 2007
- Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cellsBlood, 2006
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994